The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemiaHERMAN, Sarah E. M; LAPALOMBELLA, Rosa; BYRD, John C et al.Blood. 2011, Vol 117, Num 16, pp 4323-4327, issn 0006-4971, 5 p.Article

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765HERMAN, Sarah E. M; GORDON, Amber L; HAMDY, Ahmed et al.Blood. 2011, Vol 117, Num 23, pp 6287-6296, issn 0006-4971, 10 p.Article

Phosphatidylinositol 3-kinase-8 inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsHERMAN, Sarah E. M; GORDON, Amber L; GIESE, Neill A et al.Blood. 2010, Vol 116, Num 12, pp 2078-2088, issn 0006-4971, 11 p.Article